Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Translational Psychiatry|October 12, 2024
Modulation of neural oscillations in escitalopram treatment: a Canadian biomarker integration network in depression studyBenjamin Schwartzmann, Raaj Chatterjee, Yasaman Vaghei, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 30, 2020
Clinical, behavioral, and neural measures of reward processing correlate with escitalopram response in depression: a Canadian Biomarker Integration Network in Depression (CAN-BIND-1) ReportKatharine Dunlop, Sakina J Rizvi, Sidney H Kennedy, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 5, 2023
Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) StudyFarhana Islam, Leen Magarbeh, Samar S M Elsheikh, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 29, 2025
Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des résultats du traitement antidépresseur à l'aide des scores de risque polygéniques : Rapport sur l'étude CAN-BIND-1Leen Magarbeh, Samar S M Elsheikh, Farhana Islam, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 15, 2019
Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND reportNikita Nogovitsyn, Meghan Muller, Roberto Souza, et al.
Biological Psychiatry Global Open Science|June 12, 2025
High Baseline Plasma Anthranilic Acid Predicts Remission Upon Acute-Series Ketamine Infusion for Treatment-Resistant DepressionStephen A Murata, Zachary B Madaj, Colt D Capan, et al.
JAMA Psychiatry|February 11, 2026
One-Year Actigraphy Study of Sleep and Rest-Activity Rhythms as Markers of Relapse in DepressionAndre C Tonon, Adile Nexha, Jasmyn E A Cunningham, et al.
Psychoneuroendocrinology|July 6, 2021
Hypothalamus volume and DNA methylation of stress axis genes in major depressive disorder: A CAN-BIND study reportJee Su Suh, Laura M Fiori, Mohammad Ali, et al.
Pharmacopsychiatry|June 25, 2024
Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 StudyFarhana Islam, Amanda Lisoway, Edward S Oh, et al.
JAMA Network Open|January 4, 2020
Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With DepressionAndrey Zhdanov, Sravya Atluri, Willy Wong, et al.
Pageof 18